Analyst Price Targets — EVFM
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| March 4, 2022 12:00 am | Jeffrey Hung | Morgan Stanley | $66.25 | $55.00 | Pulse 2.0 | Evofem Biosciences (EVFM) Stock: $0.53 Price Target And Underweight Rating |
Latest News for EVFM
SAN DIEGO--(BUSINESS WIRE)---- $EVFM #BV--Women's health pioneer Evofem reported its fifth consecutive year of top line growth, with 2025 net product sales of more than $20 million.
SAN DIEGO--(BUSINESS WIRE)---- $EVFM #Fierce--Evofem CEO's fiery keynote address at Fierce JPM Week 2026 calls for “Ground-Up Reset” of Women's Health. Replay now live at fiercejpmweek.com.
SAN DIEGO--(BUSINESS WIRE)---- $EVFM #sayvagina--Evofem launched SayVaginaStore.com, expanding its 'Say Vagina' campaign addressing widespread censorship of female anatomical terms in the media.
Earnings and Valuation This table compares BetterLife Pharma and Evofem Biosciences"s revenue, earnings per share and valuation. Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio BetterLife Pharma N/A N/A -$14.78 million N/A N/A Evofem Biosciences $11.39 million 0.12 $52.98 million ($0.06) -0.18 Evofem Biosciences has higher revenue and earnings than BetterLife Pharma.
Evofem Biosciences, Inc. (NASDAQ: EVFM - Get Free Report)'s stock price crossed above its 50 day moving average during trading on Thursday. The stock has a 50 day moving average of $0.01 and traded as high as $0.0102. Evofem Biosciences shares last traded at $0.0102, with a volume of 48,050 shares traded. Evofem Biosciences Stock
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for EVFM.
U.S. House Trading
No House trades found for EVFM.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.